Montserrat Tuset

1.7k total citations
50 papers, 799 citations indexed

About

Montserrat Tuset is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Montserrat Tuset has authored 50 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Infectious Diseases, 15 papers in Epidemiology and 11 papers in Virology. Recurrent topics in Montserrat Tuset's work include HIV/AIDS drug development and treatment (30 papers), HIV/AIDS Research and Interventions (23 papers) and HIV Research and Treatment (11 papers). Montserrat Tuset is often cited by papers focused on HIV/AIDS drug development and treatment (30 papers), HIV/AIDS Research and Interventions (23 papers) and HIV Research and Treatment (11 papers). Montserrat Tuset collaborates with scholars based in Spain, Switzerland and Italy. Montserrat Tuset's co-authors include José M. Miró, Carles Codina, Elisa de Lazzari, Elena del Cacho, JM Gatell, M. Martin, Josep Mallolas, Xavier Carné, Maite Velázquez Martín and Asunción Moreno and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Kidney International.

In The Last Decade

Montserrat Tuset

47 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Montserrat Tuset Spain 15 477 211 167 135 102 50 799
Dianne Carey Australia 15 580 1.2× 176 0.8× 423 2.5× 446 3.3× 191 1.9× 28 1.2k
Jean‐Philippe Chave Switzerland 16 864 1.8× 499 2.4× 493 3.0× 474 3.5× 23 0.2× 21 1.3k
Giancarlo Orofino Italy 22 781 1.6× 299 1.4× 487 2.9× 578 4.3× 30 0.3× 75 1.3k
Yogesh Punekar United Kingdom 23 410 0.9× 343 1.6× 272 1.6× 155 1.1× 51 0.5× 67 1.5k
JM Gatell Spain 13 593 1.2× 282 1.3× 354 2.1× 255 1.9× 35 0.3× 28 805
Faten Aberra United States 14 159 0.3× 963 4.6× 84 0.5× 54 0.4× 53 0.5× 43 1.8k
R. Chris Rathbun United States 15 424 0.9× 235 1.1× 172 1.0× 101 0.7× 77 0.8× 35 729
Sreekanth K. Chaguturu United States 15 317 0.7× 240 1.1× 148 0.9× 62 0.5× 14 0.1× 26 751
Valerianna Amorosa United States 18 375 0.8× 346 1.6× 143 0.9× 286 2.1× 5 0.0× 36 888
Paola Meraviglia Italy 19 941 2.0× 368 1.7× 556 3.3× 330 2.4× 9 0.1× 61 1.3k

Countries citing papers authored by Montserrat Tuset

Since Specialization
Citations

This map shows the geographic impact of Montserrat Tuset's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Montserrat Tuset with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Montserrat Tuset more than expected).

Fields of papers citing papers by Montserrat Tuset

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Montserrat Tuset. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Montserrat Tuset. The network helps show where Montserrat Tuset may publish in the future.

Co-authorship network of co-authors of Montserrat Tuset

This figure shows the co-authorship network connecting the top 25 collaborators of Montserrat Tuset. A scholar is included among the top collaborators of Montserrat Tuset based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Montserrat Tuset. Montserrat Tuset is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Echeverría-Esnal, Daniel, et al.. (2024). Clinically important pharmacokinetic drug-drug interactions with antibacterial agents. Revista Española de Quimioterapia. 37(4). 299–322. 4 indexed citations
2.
Echeverría-Esnal, Daniel, Sergi Hernández, Ariadna Padullés, et al.. (2023). Cross-Sectional Survey on the Current Role of Clinical Pharmacists among Antimicrobial Stewardship Programmes in Catalonia: Much Ado about Nothing. Antibiotics. 12(4). 717–717. 2 indexed citations
3.
Ambrosioni, Juan, Montserrat Tuset, Mercè Brunet, et al.. (2021). Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review. Infectious Diseases and Therapy. 10(2). 1055–1064. 5 indexed citations
4.
Grau, Ana M., et al.. (2017). Polypharmacy and potential drug-drug interactions in an HIV-infected elderly population. SHILAP Revista de lepidopterología. 5 indexed citations
5.
Ferrer‐Márquez, Manuel, et al.. (2017). Fe de errores: Polifarmacia e interacciones farmacológicas potenciales en una población envejecida con infección por el VIH. Farmacia Hospitalaria. 41(6). 700–700. 1 indexed citations
6.
Nicolás, David, Juan Ambrosioni, Omar Sued, et al.. (2016). Cyclosporine A in addition to standard ART during primary HIV-1 infection: pilot randomized clinical trial. Journal of Antimicrobial Chemotherapy. 72(3). dkw462–dkw462. 9 indexed citations
7.
Manzardo, Christian, Montserrat Tuset, José M. Miró, & José M. Gatell. (2014). Interacciones graves o potencialmente letales entre antirretrovirales y otros medicamentos. Enfermedades Infecciosas y Microbiología Clínica. 33(7). e15–e30. 9 indexed citations
8.
Miró, José M., Frederic Cofán, Joan Carles Trullàs, et al.. (2012). Renal Dysfunction in the Setting of HIV/AIDS. Current HIV/AIDS Reports. 9(3). 187–199. 21 indexed citations
9.
Blasco, Antonio Javier, José Ramón Arribas, Vicente Boix, et al.. (2012). Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA/Plan Nacional sobre el Sida en 2012 para el tratamiento antirretroviral inicial en adultos infectados por el virus de la inmunodeficiencia humana (VIH). Enfermedades Infecciosas y Microbiología Clínica. 30(6). 283–293. 8 indexed citations
10.
Tuset, Montserrat, M. Martin, Elisa de Lazzari, et al.. (2011). Evaluation of antiretroviral-related errors and interventions by the clinical pharmacist in hospitalized HIV-infected patients. HIV Medicine. 12(8). 494–499. 51 indexed citations
11.
Trullàs, Joan Carles, Frederic Cofán, Montserrat Tuset, et al.. (2011). Renal transplantation in HIV-infected patients: 2010 update. Kidney International. 79(8). 825–842. 51 indexed citations
12.
Tuset, Montserrat, et al.. (2010). Características de los fármacos antivíricos frente a virus del grupo herpes actualización 2009. Enfermedades Infecciosas y Microbiología Clínica. 28(3). 199.e1–199.e33.
13.
Martin, M., Elena del Cacho, Carles Codina, et al.. (2008). Relationship between Adherence Level, Type of the Antiretroviral Regimen, and Plasma HIV Type 1 RNA Viral Load: A Prospective Cohort Study. AIDS Research and Human Retroviruses. 24(10). 1263–1268. 122 indexed citations
14.
Gómez, Marı́a, Elena del Cacho, Carles Codina, et al.. (2007). Reacciones adversas del tratamiento antirretroviral: relación entre los síntomas percibidos y el cumplimiento terapéutico. Medicina Clínica. 129(4). 127–133. 12 indexed citations
15.
Trullàs, Joan Carles, José M. Miró, Guillermina Barril, et al.. (2005). Trasplante renal en pacientes infectados por el VIH. Enfermedades Infecciosas y Microbiología Clínica. 23(6). 363–374. 10 indexed citations
16.
Tuset, Montserrat, et al.. (2002). Drug related hospital admissions. Medicina Clínica. 118(6). 4 indexed citations
17.
García, Felipe, Montserrat Plana, Gabriel Mestre, et al.. (2002). Metabolic and Immunological Effects of Antiretroviral Agents in Healthy Individuals Receiving Post-Exposure Prophylaxis. Antiviral Therapy. 7(3). 195–197. 5 indexed citations
18.
Rubio, Rafael, Juan Berenguer, José M. Miró, et al.. (2002). Recomendaciones de GESIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en pacientes adultos infectados por el virus de la inmunodeficiencia humana en el año 2002. Enfermedades Infecciosas y Microbiología Clínica. 20(6). 244–303. 38 indexed citations
19.
Bladé, Joan, Marı́a Perales, Laura Rosiñol, et al.. (2001). Thalidomide in multiple myeloma: lack of response of soft‐tissue plasmacytomas. British Journal of Haematology. 113(2). 422–424. 65 indexed citations
20.
Codina, Carles, et al.. (1999). Perioperative Antibiotic Prophylaxis in Spanish Hospitals: Results of a Questionnaire Survey. Infection Control and Hospital Epidemiology. 20(6). 436–439. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dianne Carey Breakdown of academic impact, for papers by Jean‐Philippe Chave Breakdown of academic impact, for papers by Giancarlo Orofino Breakdown of academic impact, for papers by Yogesh Punekar Breakdown of academic impact, for papers by JM Gatell Breakdown of academic impact, for papers by Faten Aberra Breakdown of academic impact, for papers by R. Chris Rathbun Breakdown of academic impact, for papers by Sreekanth K. Chaguturu Breakdown of academic impact, for papers by Valerianna Amorosa Breakdown of academic impact, for papers by Paola Meraviglia
Rankless by CCL
2026